TheraRadar
← Back
Data updated: Mar 29, 2026

PHARM ASSOC

NeurologyInfectious DiseaseGastroenterology
Generics

PHARM ASSOC is a generic drug manufacturer focused on Neurology, Infectious Disease, Gastroenterology.

1980
Since
48
Drugs
-
Trials
794
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NYSTATIN 2026-02-05
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
CYCLOSPORINE 2026-01-21
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 40%
2 drugs
Infectious Disease 20%
1 drugs
Gastroenterology 20%
1 drugs
Immunology 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Infectious Disease, Neurology
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
AbbVie big-pharma
Immunology, Neurology, Infectious Disease
GSK big-pharma
Infectious Disease, Immunology, Neurology
Takeda big-pharma
Immunology, Gastroenterology, Neurology